Clinical Trial Update: A Real-World Study of Clinical Use of Available Treatments for Pediatric Patients With Spinal Muscular Atrophy

View source ↗

Summary

Completed real-world study conducted by Novartis evaluating the use of available treatments in pediatric spinal muscular atrophy patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Muscular Atrophy, Spinal | Status: COMPLETED